Twinbeech Capital LP Merck & Co., Inc. Transaction History
Twinbeech Capital LP
- $4.99 Billion
- Q3 2024
A detailed history of Twinbeech Capital LP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Twinbeech Capital LP holds 110,492 shares of MRK stock, worth $10.8 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
110,492
Previous 488,321
77.37%
Holding current value
$10.8 Million
Previous $60.5 Million
79.25%
% of portfolio
0.25%
Previous 1.23%
Shares
9 transactions
Others Institutions Holding MRK
# of Institutions
3,819Shares Held
1.88BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$24.3 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.6 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.39 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.76 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $247B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...